Cargando…
Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls
Over the last two decades, indoleamine 2,3-dioxygenase 1 (IDO1) has attracted wide interest as a key player in immune regulation, fostering the design and development of small molecule inhibitors to restore immune response in tumor immunity. In this framework, biochemical, structural, and pharmacolo...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999677/ https://www.ncbi.nlm.nih.gov/pubmed/35409342 http://dx.doi.org/10.3390/ijms23073981 |
_version_ | 1784685245923065856 |
---|---|
author | Mammoli, Andrea Bianconi, Elisa Ruta, Luana Riccio, Alessandra Bigiotti, Carlo Souma, Maria Carotti, Andrea Rossini, Sofia Suvieri, Chiara Pallotta, Maria Teresa Grohmann, Ursula Camaioni, Emidio Macchiarulo, Antonio |
author_facet | Mammoli, Andrea Bianconi, Elisa Ruta, Luana Riccio, Alessandra Bigiotti, Carlo Souma, Maria Carotti, Andrea Rossini, Sofia Suvieri, Chiara Pallotta, Maria Teresa Grohmann, Ursula Camaioni, Emidio Macchiarulo, Antonio |
author_sort | Mammoli, Andrea |
collection | PubMed |
description | Over the last two decades, indoleamine 2,3-dioxygenase 1 (IDO1) has attracted wide interest as a key player in immune regulation, fostering the design and development of small molecule inhibitors to restore immune response in tumor immunity. In this framework, biochemical, structural, and pharmacological studies have unveiled peculiar structural plasticity of IDO1, with different conformations and functional states that are coupled to fine regulation of its catalytic activity and non-enzymic functions. The large plasticity of IDO1 may affect its ligand recognition process, generating bias in structure-based drug design campaigns. In this work, we report a screening campaign of a fragment library of compounds, grounding on the use of three distinct conformations of IDO1 that recapitulate its structural plasticity to some extent. Results are instrumental to discuss tips and pitfalls that, due to the large plasticity of the enzyme, may influence the identification of novel and differentiated chemical scaffolds of IDO1 ligands in structure-based screening campaigns. |
format | Online Article Text |
id | pubmed-8999677 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89996772022-04-12 Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls Mammoli, Andrea Bianconi, Elisa Ruta, Luana Riccio, Alessandra Bigiotti, Carlo Souma, Maria Carotti, Andrea Rossini, Sofia Suvieri, Chiara Pallotta, Maria Teresa Grohmann, Ursula Camaioni, Emidio Macchiarulo, Antonio Int J Mol Sci Article Over the last two decades, indoleamine 2,3-dioxygenase 1 (IDO1) has attracted wide interest as a key player in immune regulation, fostering the design and development of small molecule inhibitors to restore immune response in tumor immunity. In this framework, biochemical, structural, and pharmacological studies have unveiled peculiar structural plasticity of IDO1, with different conformations and functional states that are coupled to fine regulation of its catalytic activity and non-enzymic functions. The large plasticity of IDO1 may affect its ligand recognition process, generating bias in structure-based drug design campaigns. In this work, we report a screening campaign of a fragment library of compounds, grounding on the use of three distinct conformations of IDO1 that recapitulate its structural plasticity to some extent. Results are instrumental to discuss tips and pitfalls that, due to the large plasticity of the enzyme, may influence the identification of novel and differentiated chemical scaffolds of IDO1 ligands in structure-based screening campaigns. MDPI 2022-04-02 /pmc/articles/PMC8999677/ /pubmed/35409342 http://dx.doi.org/10.3390/ijms23073981 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Mammoli, Andrea Bianconi, Elisa Ruta, Luana Riccio, Alessandra Bigiotti, Carlo Souma, Maria Carotti, Andrea Rossini, Sofia Suvieri, Chiara Pallotta, Maria Teresa Grohmann, Ursula Camaioni, Emidio Macchiarulo, Antonio Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls |
title | Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls |
title_full | Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls |
title_fullStr | Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls |
title_full_unstemmed | Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls |
title_short | Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls |
title_sort | critical assessment of a structure-based screening campaign for ido1 inhibitors: tips and pitfalls |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999677/ https://www.ncbi.nlm.nih.gov/pubmed/35409342 http://dx.doi.org/10.3390/ijms23073981 |
work_keys_str_mv | AT mammoliandrea criticalassessmentofastructurebasedscreeningcampaignforido1inhibitorstipsandpitfalls AT bianconielisa criticalassessmentofastructurebasedscreeningcampaignforido1inhibitorstipsandpitfalls AT rutaluana criticalassessmentofastructurebasedscreeningcampaignforido1inhibitorstipsandpitfalls AT riccioalessandra criticalassessmentofastructurebasedscreeningcampaignforido1inhibitorstipsandpitfalls AT bigiotticarlo criticalassessmentofastructurebasedscreeningcampaignforido1inhibitorstipsandpitfalls AT soumamaria criticalassessmentofastructurebasedscreeningcampaignforido1inhibitorstipsandpitfalls AT carottiandrea criticalassessmentofastructurebasedscreeningcampaignforido1inhibitorstipsandpitfalls AT rossinisofia criticalassessmentofastructurebasedscreeningcampaignforido1inhibitorstipsandpitfalls AT suvierichiara criticalassessmentofastructurebasedscreeningcampaignforido1inhibitorstipsandpitfalls AT pallottamariateresa criticalassessmentofastructurebasedscreeningcampaignforido1inhibitorstipsandpitfalls AT grohmannursula criticalassessmentofastructurebasedscreeningcampaignforido1inhibitorstipsandpitfalls AT camaioniemidio criticalassessmentofastructurebasedscreeningcampaignforido1inhibitorstipsandpitfalls AT macchiaruloantonio criticalassessmentofastructurebasedscreeningcampaignforido1inhibitorstipsandpitfalls |